跳至主要内容
临床试验/IRCT20210413050952N1
IRCT20210413050952N1招募中未知

Evaluation of safety and efficacy of CardiaMed heart valve prosthesis in a multicentral study on patients undergoing open heart valve surgery

Dastavard-e-Sina Co.0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 65 years(—)
性别
All

入选标准

  • Candidate for mechanical valve replacement due to rheumatic heart valve disease
  • Isolated mitral valve replacement

排除标准

  • Patients undergoing re-do surgeries
  • Patients with left ventricular ejection fraction =35%
  • Concomitant coronary artery bypasses graft surgery
  • Concomitant other valve surgeries
  • Patients suspicious for native valve endocarditis
  • Patients with contraindicated warfarin consumption

研究者

发起方
Dastavard-e-Sina Co.

相似试验